What is BPMC's current dividend yield?

BPMC (Blueprint Medicines Corporation) yields 1.54% based on an annual dividend of $2.00 per share at a stock price of $129.46. Dividends are paid quarterly.

How much does $10,000 in BPMC generate in dividends?

$10,000 invested in BPMC at 1.54% yield generates approximately $154.49 per year, or $12.87 per month in dividend income. With DRIP reinvestment, this compounds significantly over time.

How much does $50,000 in BPMC pay in dividends?

$50,000 in BPMC generates approximately $772.44 per year at the current 1.54% yield.

Is BPMC a good dividend stock in 2026?

BPMC pays quarterly dividends with a 1.54% yield and 50% payout ratio. The 5-year dividend CAGR is 5%. The 50% payout ratio is considered sustainable. This is not financial advice.

Home › Calculator › BPMC Dividend Calculator 2026

BPMC Dividend DRIP Calculator 2026

1.54% YieldHealthcare

Blueprint Medicines Corporation · NASDAQ

Price: $129.46 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD

Annual dividend

$2.00

per share

Forward yield

1.54%

at current price

1Y div growth

+0%

CAGR

5Y div growth

+0%

CAGR

Payout ratio

50%

Sustainable

Calculator settings

ACCOUNT TYPE

INITIAL INVESTMENT

MONTHLY CONTRIBUTION$0/mo

$0$500$1k$2k

INVESTMENT HORIZON10 years

1y10y20y30y

PRICE GROWTH / YEAR100%

DIVIDEND GROWTH / YEAR0%

DRIP Reinvestment

Auto-reinvest all dividends

Monthly passive income

$13.07

after 10 years · DRIP ✓

Yield on cost: 1.57%

Annual dividend income

$156.88

after 10 years

Total dividends: $1.6K

Real Yield · Inflation Adjusted

-1.26%= 1.54% yield − 2.8% CPI

iCalculated by subtracting the current 12-month CPI (2.8%) from the forward yield. Yield is below inflation — real purchasing power is being eroded.

Portfolio (DRIP)

$10.40M

Portfolio (no DRIP)

$10.24M

DRIP bonus

+$157.3K

Total return

+103888.6%

📊 See how BPMC actually performed since 2021 →

Real historical prices · DRIP simulation · DCA backtest

Last 5 Years →

Year-by-year projection

DRIP ON ✓ · Roth IRA / ISA

Year	Shares	Annual income	Monthly income	Portfolio value	Yield on cost	Cumul. dividends
1	77.84	$154.49	$12.87	$20,154	1.54%	$154
2	78.14	$155.68	$12.97	$40,465	1.56%	$310
3	78.29	$156.28	$13.02	$81,086	1.56%	$466
4	78.37	$156.58	$13.05	$162,328	1.57%	$623
5	78.41	$156.74	$13.06	$324,812	1.57%	$780
6	78.42	$156.81	$13.07	$649,781	1.57%	$937
7	78.43	$156.85	$13.07	$1,299,720	1.57%	$1,093
8	78.44	$156.87	$13.07	$2,599,596	1.57%	$1,250
9	78.44	$156.88	$13.07	$5,199,349	1.57%	$1,407
10	78.44	$156.88	$13.07	$10,398,855	1.57%	$1,564

Portfolio growth: DRIP vs No DRIP

Annual dividend income growth

💡 What-if scenarios

Click to apply scenario to the calculator

☕

Daily coffee money

+$150/mo for 15 years

$392.36M

$15.42/month income

DCA bonus vs no DCA: +$59.59M

📱

Skip one gadget/mo

+$100/mo for 20 years

$11919.89M

$14.64/month income

DCA bonus vs no DCA: +$1271.31M

🚀

Serious wealth mode

+$500/mo for 25 years

$544164.08M

$20.88/month income

DCA bonus vs no DCA: +$203409.26M

🎯 When BPMC pays your bills

Year your monthly dividend income covers each expense (based on current settings)

📺

Netflix

$18/month

Increase investment or time

🎵

Spotify

$11/month

✓ Year 1

📱

Phone bill

$60/month

Increase investment or time

🛒

Gas & groceries

$300/month

Increase investment or time

🚗

Car payment

$500/month

Increase investment or time

🏠

Rent (avg US)

$1,500/month

Increase investment or time

🏝️

Financial freedom

$5,000/month

Increase investment or time

Share your BPMC snowball 📈

$10,000 in BPMC → $10.40M in 10 years · $13.07/month

Post on X

About Blueprint Medicines Corporation (BPMC) — Dividend Analysis 2026

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally available and potent inhibitor for the treatment of hepatocellular carcinoma. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered solid tumors, medullary thyroid carcinoma, and other solid tumors; BLU-701 and BLU-945 for the treatment of epidermal growth factor receptor driven non-small-cell lung carcinoma (NSCLC); and BLU-451 to treat NSCLC in patients with epidermal growth factor receptor gene (EGFR) exon 20 insertion mutations. In addition, the company is developing BLU-782, for the treatment of fibrodysplasia ossificans progressive; BLU- 222 to treat patients with cyclin E aberrant cancers; and BLU-852 for the treatment of advanced cancers. It has collaboration and license agreements with Clementia Pharmaceuticals, Inc.; Proteovant Therapeutics; CStone Pharmaceuticals; Genentech, Inc.; F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Zai Lab (Shanghai) Co., Ltd. The company was formerly known as Hoyle Pharmaceuticals, Inc. and changed its name to Blueprint Medicines Corporation in June 2011. Blueprint Medicines Corporation was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.

Is BPMC a good dividend investment in 2026?

BPMC offers a 1.54% forward yield with a 50% payout ratio. Strand Safety Score: 60/100 (Moderate Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.

BPMC DRIP calculator — what's the difference?

With DRIP on a $10,000 investment over 10 years, your BPMC portfolio grows to $10.40M vs $10.24M without reinvestment. This is the compound interest effect in action.

BPMC dividend growth history & forecast

BPMC has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 1.54%.

Compare BPMC with similar stocks

⚖️ Compare BPMC vs SCHD →

Expert Reviewed byVictor StrandVERIFIED

This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.

📬

Get Your Full BPMC DRIP Report by Email

We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.

Free forever. No spam. Unsubscribe anytime.

Ready to invest? Open BPMC position with:

🛡️ Dividend Safety Analysis

Strand Safety Score™ — BPMC

Proprietary model · FCF Coverage (40) · Debt Leverage (30) · Earnings Momentum (30)

/100

Moderate Risk

Cash Flow Coverage-1.5× coverage

0 / 40 pts

0/40

Company generates negative FCF ($-197M) — borrowing to pay dividends

Debt Leverage0.0× Debt/EBITDA

30 / 30 pts

30/30

Debt/EBITDA 0.0× — low leverage, balance sheet is strong

Earnings Momentum-0.1B → -0.5B → -0.6B

30 / 30 pts

30/30

Net income grew for 2 consecutive years — strong earnings momentum

OVERALL ASSESSMENT

Dividend at moderate risk — monitor coverage and debt closely.

STRAND SCORE

/100

Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.

🌍 BPMC Yield by Country & Account Type

Real after-tax yield depends on where you live and how you hold BPMC.

Gross yield

1.54%

Tax rate

15.00%

After-tax yield

1.31%

Real yield (−CPI)

-1.49%

Account/Country	Tax Rate	After-tax Yield	Real Yield	$10K Annual Income
🇺🇸 Roth IRA / 401k	0%	1.54%	-1.26%	$154 / yr
🇺🇸 US Taxable (15%) ✓	15%	1.31%	-1.49%	$131 / yr
🇺🇸 US Taxable (20%)	20%	1.23%	-1.57%	$123 / yr
🇬🇧 UK ISA	0%	1.54%	-1.26%	$154 / yr
🇬🇧 UK Taxable	8.75%	1.41%	-1.39%	$141 / yr
🇨🇦 TFSA	0%	1.54%	-1.26%	$154 / yr
🇨🇦 CA Taxable	25%	1.16%	-1.64%	$116 / yr
🇦🇺 Super (pension)	15%	1.31%	-1.49%	$131 / yr
🇦🇺 AU Taxable	30%	1.08%	-1.72%	$108 / yr
🇩🇪 DE Taxable	26.375%	1.13%	-1.67%	$113 / yr
🇫🇷 FR Taxable	30%	1.08%	-1.72%	$108 / yr

Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.

🎯 BPMC Income Goal & Break-Even

Dividend Break-Even

50yr+

Years for dividends to fully repay your BPMC investment of $129.46/share (🇺🇸 US Taxable (15%) · 15.00% tax)

$10K invested · 10 Years

Dividends earned (DRIP)

$1.3K

Lost to inflation (2.8% CPI)

−$2.5K

Real purchasing power gain

$-1145.30

12-month CPI (US BLS via FMP economic-indicators).

How much do I need to invest in BPMC for:

Shares needed

14,118

Capital required

$1,827,716

Monthly income

$2,000

Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).

📅 BPMC Dividend Payment Schedule

BPMC pays quarterly — 4 times per year. Next ex-div: TBD.

Jan

Feb

Mar

💰

Apr

May

Jun

💰

Jul

Aug

Sep

💰

Oct

Nov

Dec

💰

10 shares

$4.25 / payment

$17.00 / year after tax

100 shares

$42.50 / payment

$170.00 / year after tax

1,000 shares

$425.00 / payment

$1700.00 / year after tax

📊 BPMC vs Healthcare Benchmarks

How BPMC compares to typical Healthcare averages.

Benchmark: Healthcare

Dividend Yield▼-1.26% vs sectorBelow avg

BPMC

1.54%

avg

2.80%

5Y Dividend CAGR▼-6.80% vs sectorBelow avg

BPMC

0.00%

avg

6.80%

Payout Ratio▲-5.00% vs sectorBetter

BPMC

50.00%

avg

55.00%

Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for BPMC sourced from FMP /financial-growth endpoint — real data, not estimates.

🏛️ BPMC Insider Activity

When executives buy their own stock, it's a signal they believe in the dividend's sustainability.

Insider	Title	Type	Date	Shares	Price	Total Value
Landsittel Michael	officer: Chief Financial Officer	A-Award	2025-07-17	21,353	—	—
Landsittel Michael	officer: Chief Financial Officer	D-Return	2025-07-17	51,102	—	—
Landsittel Michael	officer: Chief Financial Officer	D-Return	2025-07-17	25,000	$61.31	$1.53M
Landsittel Michael	officer: Chief Financial Officer	D-Return	2025-07-17	25,000	$43.15	$1.08M
Landsittel Michael	officer: Chief Financial Officer	D-Return	2025-07-17	10,000	$15.01	$150.1K
Landsittel Michael	officer: Chief Financial Officer	U-Tender	2025-07-17	43,175	—	—
Landsittel Michael	officer: Chief Financial Officer	D-Return	2025-07-17	19,500	$86.60	$1.69M
Landsittel Michael	officer: Chief Financial Officer	D-Return	2025-07-17	25,000	$54.13	$1.35M
Landsittel Michael	officer: Chief Financial Officer	D-Return	2025-07-17	25,000	$95.12	$2.38M
Landsittel Michael	officer: Chief Financial Officer	D-Return	2025-07-17	22,000	$96.57	$2.12M

Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.

🎯

Analyst Price Target

Wall Street consensus

Current Price

$129.46

Analyst Target

$113.07

Upside / Downside

-12.7%

Range

$41.00 – $155.00

💡 If BPMC reaches the analyst target of $113.07, investors buying today at $129.46 would see an effective yield of 1.77% on shares purchased at target price — vs 1.54% at current price.

Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.

🔬

Financial Health Scores

Altman Z-Score

3.68

✅ Safe Zone — low bankruptcy risk

Safe: >3.0 · Grey: 1.81–3.0 · Distress: <1.81

Piotroski F-Score

4/9

⚠️ Moderate fundamentals

Strong: 7–9 · Moderate: 4–6 · Weak: 0–3

Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.

🌍

Geographic Revenue Breakdown

Where BPMC earns its money

UNITED STATES88%

Non-US12%

💡 International revenue may have additional withholding tax implications for non-US investors. Check your country's tax treaty with the US before investing.

Revenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.

📊 About This Data

Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.

🔄 Updated daily🔒 SEC EDGAR source✍️ Reviewed by Victor Strand

📊 Data via FMP🔒 SEC EDGAR🔄 Updated daily✍️ Reviewed by Victor Strand 📬 Report data error

Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the BPMC dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →